Alison S. Long
CIK: 0001891712
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TSHA
Taysha Gene Therapies, Inc.
Director
Discretionary Trading P&L
Holdings
About Long Alison S
Long Alison S (SEC CIK 0001891712) files insider reports with the SEC as Director of Taysha Gene Therapies, Inc. (TSHA).
Signal8 holds 2 ownership filings by Long Alison S, all Form 4s, filed between Jun 4, 2025 and Jun 2, 2026. Those filings report 2 transactions, from Jun 2, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Long Alison S's filings is in DALLAS, TX.
Recent filings by Long Alison S
Other insiders filing for Taysha Gene Therapies, Inc. (TSHA)
- Nagendran Sukumar, President and Head of R&D
- Stalfort John A III, Director
- Donenberg Phillip B., Director
- Sepp-Lorenzino Laura, Director
- Alam Kamran, CHIEF FINANCIAL OFFICER
- Nolan Sean P., Chief Executive Officer